Acro Biomedical (ACBM) Net Cash Flow Growth (3y) (2018 - 2025)
Acro Biomedical (ACBM) Net Cash Flow Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | 72.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 72.08% |
| Sep 30, 2025 | 1.73% |
| Jun 30, 2025 | 91.33% |
| Mar 31, 2025 | -26.01% |
| Dec 31, 2024 | 84.41% |
| Sep 30, 2024 | 84.53% |
| Jun 30, 2024 | -84.05% |
| Mar 31, 2024 | -26.75% |
| Sep 30, 2023 | 66.63% |
| Jun 30, 2023 | 30.65% |
| Mar 31, 2023 | -36.95% |
| Dec 31, 2022 | -164.12% |
| Sep 30, 2022 | 28.32% |
| Jun 30, 2022 | -109.88% |
| Mar 31, 2022 | 108.43% |
| Dec 31, 2021 | -53.68% |
| Sep 30, 2021 | -159.85% |
| Jun 30, 2021 | 34.06% |
| Mar 31, 2021 | -76.21% |
| Sep 30, 2020 | -26.12% |